Pages
Products

Human CCR5 Stable Cell Line - HEK293T

For research use only. Not intended for any clinical use.

Cat. No. :   CSC-RG1801

Host Cell :   HEK293T Size :   >1x106 frozen cells/vial

Inquire for Price

Cell Line Information

Cell Culture Information

Safety and Packaging

Gene Information

Cat. No. CSC-RG1801
Description This cell line is engineered to stably overexpress Human CCR5 in HEK293T cells.
Target Gene CCR5
Gene Species Homo sapiens (Human)
Host Cell HEK293T
Host Cell Species Homo sapiens (Human)
Applications

1. Gene expression studies

2. Signaling pathway research

3. Drug screening and toxicology

4. Research on the mechanisms of GPCR-related diseases

Size >1x106 frozen cells/vial
Stability Validated for at least 10 passages
Quality Control Negative for bacteria, yeast, fungi and mycoplasma.
Storage Liquid nitrogen
Shipping Dry ice
Revival Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media.
Growth Properties Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Split at 80-90% confluence, approximately 1:3-1:6.
Mycoplasma Negative
Format One frozen vial containing millions of cells
Storage Liquid nitrogen
Safety Considerations The following safety precautions should be observed.
1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum.
2. No eating, drinking or smoking while handling the stable line.
3. Wash hands after handling the stable line and before leaving the lab.
4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells.
5. All waste should be considered hazardous.
6. Dispose of all liquid waste after each experiment and treat with bleach.
Ship Dry ice
Gene Name CCR5 chemokine (C-C motif) receptor 5 (gene/pseudogene) [ Homo sapiens ]
Gene Symbol CCR5
Synonyms CKR5; CCR-5; CD195; CKR-5; CCCKR5; CMKBR5; IDDM22; CC-CKR-5
Gene Description chemokine (C-C motif) receptor 5
GeneID 1234
Uni ProtID P51681
mRNA Refseq NM_000579.3
Protein Refseq NP_000570.1
Chromosome Location 3p21.31
Function C-C chemokine binding; C-C chemokine receptor activity; C-C chemokine receptor activity; actin binding; chemokine (C-C motif) ligand 5 binding; chemokine receptor activity; coreceptor activity; phosphatidylinositol phospholipase C activity; protein binding;
Pathway Binding and entry of HIV virion, organism-specific biosystem; Chemokine receptors bind chemokines, organism-specific biosystem; Chemokine signaling pathway, organism-specific biosystem; Chemokine signaling pathway, conserved biosystem; Class A/1 (Rhodopsin-like receptors), organism-specific biosystem; Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem;
MIM 601373
Quick Inquiry

Background

Case Study

Q & A

Customer Reviews

Human CCR5 encodes a CC chemokine receptor expressed on multiple leukocyte subsets and a major coreceptor for entry of R5-tropic HIV-1. Its activation by CCL3, CCL4, and CCL5 initiates Gi/o-coupled signaling linked to calcium mobilization, migration, and immune-cell activation, making receptor abundance and cellular context important determinants of experimental response. This product is a stable HEK293T cell line engineered to maintain elevated expression of human CCR5. This cell line is engineered to stably overexpress Human CCR5 in HEK293T cells. HEK293T cells combine a human cellular background with high transfection efficiency and convenient propagation, making them useful for follow-on genetic manipulation and assay development. Stable integration reduces the experiment-to-experiment variability associated with transient transfection and supports repeated use across assay campaigns.

Functionally, the line is intended to provide consistent access to human CCR5-dependent biology. It is particularly suitable for chemokine pharmacology, antagonist and antibody screening, receptor occupancy or internalization studies, HIV-entry research with appropriate complementary systems, and investigation of immune trafficking and inflammatory disease. As a defined receptor-overexpression model, the cell line complements primary cells and tissue-derived systems by isolating target-dependent signaling from the complexity of mixed receptor populations. Its stable phenotype supports comparative pharmacology across compound series, biologic formats, and repeated screening campaigns, while preserving the same host-cell background for mechanistic interpretation. The model also provides a consistent framework for linking receptor occupancy to proximal signaling, receptor trafficking, and downstream cellular responses relevant to target validation and drug discovery. Receptor-focused datasets generated with this line can clarify ligand potency, efficacy, selectivity, desensitization, and internalization within a single cellular context.

Many G protein-coupled receptors (GPCRs) transduce signals via more than one subtype of heterotrimeric G protein. For instance, CCR5-which serves as a co-receptor for HIV-1 entry-typically signals through the heterotrimeric G protein Gi. However, CCR5 also exhibits biased G protein signaling; certain chemokine analogs can induce a shift toward the Gq pathway, thereby triggering Ca2+ signaling. Here, researchers found that in CCR5-expressing HEK293T cells, chemokine-mediated Ca2+ flux can be primed and enhanced by ATP pretreatment. Furthermore, agonist-induced lysosomal exocytosis leads to the release of ATP into the extracellular environment, thereby amplifying cellular signaling networks. ATP is rapidly degraded, sequentially converting into ADP, AMP, and adenosine; these molecules can respectively activate distinct purinergic receptors on the cell surface. Endogenous Gq-coupled purinergic P2Y receptors amplify Ca2+ signals and facilitate the convergence of signaling pathways between Gi-coupled and Gq-coupled receptors. The secretion of GPCR ligands-such as chemokines, opioids, and monoamines-is often accompanied by the co-release of ATP, resulting in a synergistic effect on Ca2+ signaling. These findings indicate that signaling crosstalk between ATP-activated purinergic receptors and other Gi-coupled GPCRs constitutes a key synergistic mechanism for amplifying intracellular Ca2+ signal responses.

Here, researchers co-incubated CCR5-expressing cells with broad-spectrum G-protein and purinergic receptor inhibitors and stimulated them with the same ligands, but omitted the dual-injection step (Figure 1). The results showed that injection of buffer alone did not induce significant changes in Ca2+ flux (Figure 1a); however, in the buffer-incubated control group, ATP injection elicited the greatest change in Ca2+ flux, with a mean RFU value of 35,000 (Figure 1b). Both the non-selective adenosine receptor inhibitors CGS15943 and YM significantly attenuated this response. Regarding the Ca2+ flux induced by ATPγS stimulation, only YM exerted an inhibitory effect, whereas CGS15943 had no impact; this is because ATPγS does not degrade to produce adenosine capable of stimulating adenosine receptors (Figure 1e). CGS15943 also had no effect on the Ca2+ flux induced by carbachol stimulation (Figure 1f); this response was inhibited only by G-protein blockers (YM and PTX) and the non-selective P2 purinergic receptor antagonist suramin. This observation was unexpected, as there have been no prior reports of muscarinic M3 receptor activation being influenced by purinergic receptors; however, the inhibitory effect of suramin might be explained by its ability to non-specifically block the coupling of G proteins to GPCRs.

Figure 1. CCR5-expressing HEK293T cells were incubated with broadly acting inhibitors of G proteins and purinergic receptors.Figure 1. CCR5-expressing HEK293T cells were incubated with broadly acting inhibitors of G proteins and purinergic receptors. (Horioka M, et al., 2021)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Consistent Platform for CCR5 Assays

We were pleased with the overall performance and usability of this CCR5 stable cell line. The HEK293T background was straightforward to maintain, and the stable-expression format supported consistent experimental planning. It has served as a useful cellular platform for receptor pharmacology, ligand characterization, and inhibitor screening.

Italy

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction